Nurix Therapeutics GAAP EPS of -$0.82, revenue of $13.6M
Source: SeekingAlpha
2026-01-28 16:52:17 ET
More on Nurix Therapeutics
- Nurix Therapeutics: Why This Company Could Double In Value?
- Nurix Therapeutics, Inc. (NRIX) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
- Nurix Therapeutics, Inc. (NRIX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Seeking Alpha’s Quant Rating on Nurix Therapeutics
- Historical earnings data for Nurix Therapeutics
Read the full article on Seeking Alpha
For further details see:
Nurix Therapeutics GAAP EPS of -$0.82, revenue of $13.6M
Nurix Therapeutics Inc.
NASDAQ: NRIX
NRIX Trading
-4.2% G/L:
$14.725 Last:
188,705 Volume:
$14.98 Open:
NRIX Latest News
February 22, 2026 01:32:40 pm
Nurix Stock Is Down 6% This Past Year, but One Biotech Fund Still Boosted Its Bet By $63 Million
January 28, 2026 04:01:00 pm
Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides a Corporate Update
NRIX Stock Data
$1,687,653,827
95,232,629
0.17%
45
N/A
Biotechnology & Life Sciences
Healthcare
US
Brisbane
